— Know what they know.
Not Investment Advice
Also trades as: GIS.DE (XETRA) · $vol 0M · GILD.SW (SIX)

GILD NASDAQ

Gilead Sciences, Inc.
1W: -1.2% 1M: -1.8% 3M: -13.8% YTD: +7.3% 1Y: +22.1% 3Y: +83.5% 5Y: +128.2%
$134.36
+3.86 (+2.96%)
 
Weekly Expected Move ±3.3%
$121 $125 $130 $134 $138
NASDAQ · Healthcare · Drug Manufacturers - General · Alpha Radar Neutral · Power 56 · $166.8B mcap · 1.24B float · 0.495% daily turnover · Short 36% of daily vol

📊 Key Metrics

TTM
$30B
Revenue
+3.5% YoY
$9B
Net Income
+54.5% YoY
$10B
Free Cash Flow
+3.9% YoY
79.2%
Gross Margin
37.2%
Op. Margin
29.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE43.9%
ROA15.6%
ROIC26.7%

Valuation

P/E18.1
P/B7.1
EV/EBITDA14.2

Leverage

Debt/Equity1.09
Current Ratio1.68
Interest Cov.11.2x

Quality Scores

Piotroski F9/9
Altman Z4.18
Beneish M-2.55

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms